How do neurotransmitter imbalances affect memory in ADHD?Â
ADHD is closely linked to difficulties with memory and executive function because the brain’s chemical messengers, dopamine and noradrenaline, do not work as efficiently as they should. These neurotransmitters help the brain focus, manage attention, and hold information in mind. When signalling is disrupted, it becomes harder to sustain focus long enough to encode memories or retrieve them when needed. According to recent research in Nature Reviews Disease Primers (2024) and PMC Neurobiology Reviews (2023), these imbalances interfere with communication between fronto-striatal, fronto-parietal, and hippocampal networks that are crucial for working memory and attention.
What guidelines say (NICE / NHS)
The NICE ADHD guideline (NG87) explains that ADHD affects attention, impulse control, and executive functions such as working memory and planning. It recommends assessing how these cognitive difficulties impact education, work, and relationships during diagnosis and care. According to NICE recommendations, ADHD medications act on dopamine and noradrenaline pathways to enhance attention and focus. UK clinical materials based on NG87 also highlight that combining medication with structure, planners, and environmental supports can reduce memory-related difficulties.
Dopamine, noradrenaline and memory-related networks
Research shows that dopamine regulates reward, motivation, and reinforcement learning, while noradrenaline supports alertness, attention, and mental clarity. Together they stabilise prefrontal cortical activity and help filter out distractions. Findings from a 2023 neurobiology review indicate that reduced catecholamine signalling in ADHD weakens fronto-striatal and fronto-parietal circuits, which are responsible for working memory and goal management. As a result, people with ADHD often lose track of information or struggle to complete tasks requiring sustained focus.
Affected brain circuits and fMRI evidence
Brain-imaging studies show that these neurotransmitter changes lead to functional and structural differences in key memory networks. A 2023 meta-analysis found reduced activation in the prefrontal and striatal regions during working-memory tasks, suggesting weaker control over information processing. Similarly, a 2024 fMRI connectivity study in adults with ADHD showed abnormal communication between frontal, parietal, and sensory areas, meaning the brain networks that normally cooperate to hold and manipulate information are less synchronised.
How neurotransmitter imbalance disrupts memory
When dopamine and noradrenaline levels are low or unstable, neurons in the prefrontal cortex cannot maintain consistent firing patterns. This instability reduces the brain’s ability to keep goals active or retrieve recent information. Evidence from the Default-Mode Network Review (2025) suggests that overactivity in mind-wandering networks interferes with attention-focused circuits, further disrupting memory recall and task performance.
Medication and clinical meaning
Treatment aims to restore balance in dopamine and noradrenaline systems. A 2024 systematic review found that stimulant medications such as methylphenidate improve working memory and attention by increasing catecholamine levels in prefrontal and striatal regions. Non-stimulant medicines like atomoxetine also enhance noradrenaline activity but may have smaller effects on working memory. According to NICE guidance, medication works best when combined with psychoeducation, structured routines, and behavioural strategies to strengthen memory and focus in daily life.
Key takeaway
ADHD affects memory because dopamine and noradrenaline imbalances reduce the brain’s ability to stabilise and maintain information in working memory. By improving chemical balance and prefrontal efficiency, medication helps restore focus and recall. When combined with behavioural support and environmental structure, this approach makes memory and attention more reliable in everyday life.
